Author Archives: Gideon M. Hirschfield

Many thanks to Dong et al for their correspondence regarding our phase II randomized, controlled trial (NCT00550862) of obeticholic acid (OCA) in primary biliary cirrhosis (PBC).1 Notably, we were able to demonstrate biochemical efficacy of OCA in pat… Continue reading →